Does T790M disappear? Successful gefitinib rechallenge after T790M disappearance in a patient with EGFR-mutant non-small-cell lung cancer.

Abstract

prognosis of patients with lung cancer harboring activating EGFr mutation. J Thorac Oncol 2012;7:1640–1644. 2. oxnard Gr, Arcila ME, Sima CS, et al. Acquired resistance to EGFr tyrosine kinase inhibitors in EGFr-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation. Clin Cancer Res 2011;17:1616–1622. 3. rosell r… (More)
DOI: 10.1097/JTO.0b013e318282e047

2 Figures and Tables

Topics

  • Presentations referencing similar topics